US genomic cancer profiling firm FMI heads to China, where access to new therapies lags
June 13, 2017 at 00:41 AM EDT
Roche-backed Foundation Medicine will bring its genomic sequencing of tumors to China in the third quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|